Nexvet Biopharma plc IPO Research Information

Nexvet Biopharma plc IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Nexvet Biopharma plc, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Nexvet Biopharma plc	NVET - NASDAQ	$13.00-$16.00	$10.00	$9.12	4 million	2/5/2015
Underwriter(s): BofA Merrill Lynch, Cowen & Co.
Co-Manager(s): Piper Jaffray, JMP Securities
Industry: Health Care
Filing(s): Filed 2014-12-30 Terms Added 2015-01-26

Nexvet Biopharma plc Quote & Chart - Click for current quote - NVET

About Nexvet Biopharma plc (adapted from Nexvet Biopharma plc prospectus):
They are a clinical-stage biopharmaceutical company focused on transforming the therapeutic market for companion animals by developing and commercializing novel, species-specific biologics based on human biologics.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "NVET" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.